Detection of intracellular HIV-1 Rev protein by flow cytometry

R J Rigg1, J S Dando, S Escaich

  • 1Progenesys, Palo Alto, CA 94304, USA.

Insights

Researchers developed a flow cytometry assay to quantify human immunodeficiency virus type 1 (HIV-1) Rev protein levels. This method aids HIV research and gene therapy by measuring Rev wild type and RevM10 proteins in infected cells.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • The Rev trans-activator protein is crucial for human immunodeficiency virus type 1 (HIV-1) replication, regulating viral structural protein expression.
  • Accurate quantification of intracellular Rev protein levels is essential for understanding HIV-1 pathogenesis and developing therapeutic strategies.

Purpose of the Study:

  • To develop and validate a quantitative flow cytometry assay for intracellular steady-state levels of HIV-1 Rev proteins (wild type and RevM10).
  • To compare different fixation and permeabilization techniques for optimizing Rev protein detection.
  • To assess the applicability of the assay for various cell types and HIV-1 infection models.

Main Methods:

  • Quantitative flow cytometry assay development.
  • Comparison of three distinct fixation and permeabilization protocols.
  • Detection of intracellular Rev wild type and RevM10 proteins.
  • Detection of HIV-Tat protein as a secondary validation.

Main Results:

  • The developed flow cytometry assay effectively quantifies intracellular Rev protein levels.
  • Different fixation and permeabilization methods impact signal magnitude and population discrimination.
  • The assay is applicable to diverse cell types, including primary cells and cell lines, infected with HIV-1.
  • The assay successfully detected a second intracellular protein, HIV-Tat.

Conclusions:

  • A robust flow cytometry assay for quantifying intracellular HIV-1 Rev proteins has been established.
  • This assay is a valuable tool for analyzing Rev expression in HIV-infected cells.
  • The assay can aid in optimizing the delivery of the RevM10 gene for gene therapy applications in HIV-1 treatment.

Related Concept Videos